These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34250941)

  • 1. Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    Sible IJ; Bangen KJ; Blanken AE; Ho JK; Nation DA
    J Alzheimers Dis; 2021; 83(1):65-75. PubMed ID: 34250941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease.
    Nation DA; Delano-Wood L; Bangen KJ; Wierenga CE; Jak AJ; Hansen LA; Galasko DR; Salmon DP; Bondi MW
    J Alzheimers Dis; 2012; 30(3):595-603. PubMed ID: 22451309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set.
    Alosco ML; Duskin J; Besser LM; Martin B; Chaisson CE; Gunstad J; Kowall NW; McKee AC; Stern RA; Tripodis Y
    J Alzheimers Dis; 2017; 57(3):953-968. PubMed ID: 28304301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.
    Alosco ML; Sugarman MA; Besser LM; Tripodis Y; Martin B; Palmisano JN; Kowall NW; Au R; Mez J; DeCarli C; Stein TD; McKee AC; Killiany RJ; Stern RA
    J Alzheimers Dis; 2018; 63(4):1347-1360. PubMed ID: 29843242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline.
    Ma Y; Blacker D; Viswanathan A; van Veluw SJ; Bos D; Vernooij MW; Hyman BT; Tzourio C; Das S; Hofman A
    Neurology; 2021 Jun; 96(23):e2812-e2823. PubMed ID: 33903194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trajectories of Cognitive Decline in Brain Donors With Autopsy-Confirmed Alzheimer Disease and Cerebrovascular Disease.
    Frank B; Ally M; Tripodis Y; Puzo C; Labriola C; Hurley L; Martin B; Palmisano J; Chan L; Steinberg E; Turk K; Budson A; O'Connor M; Au R; Qiu WQ; Goldstein L; Kukull W; Kowall N; Killiany R; Stern R; Stein T; McKee A; Mez J; Alosco M
    Neurology; 2022 Jun; 98(24):e2454-e2464. PubMed ID: 35444054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study.
    Jellinger KA; Attems J
    Acta Neuropathol; 2003 Jan; 105(1):14-7. PubMed ID: 12471455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.
    Weissberger GH; Gollan TH; Bondi MW; Nation DA; Hansen LA; Galasko D; Salmon DP
    J Alzheimers Dis; 2019; 67(1):291-302. PubMed ID: 30636736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
    Arvanitakis Z; Capuano AW; Leurgans SE; Bennett DA; Schneider JA
    Lancet Neurol; 2016 Aug; 15(9):934-943. PubMed ID: 27312738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
    Rabin JS; Nichols E; La Joie R; Casaletto KB; Palta P; Dams-O'Connor K; Kumar RG; George KM; Satizabal CL; Schneider JA; Pa J; Brickman AM
    Brain; 2022 Aug; 145(8):2823-2833. PubMed ID: 35759327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.
    Wijesinghe P; Shankar SK; Yasha TC; Gorrie C; Amaratunga D; Hulathduwa S; Kumara KS; Samarasinghe K; Suh YH; Steinbusch HW; De Silva KR
    J Alzheimers Dis; 2016 Oct; 54(4):1607-1618. PubMed ID: 27589527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?
    Crum J; Wilson J; Sabbagh M
    Alzheimers Res Ther; 2018 Oct; 10(1):104. PubMed ID: 30285877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.
    Xu C; Apostolova LG; Oblak AL; Gao S
    J Alzheimers Dis; 2020; 73(4):1305-1311. PubMed ID: 31929164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease.
    Bangen KJ; Nation DA; Delano-Wood L; Weissberger GH; Hansen LA; Galasko DR; Salmon DP; Bondi MW
    Alzheimers Dement; 2015 Apr; 11(4):394-403.e1. PubMed ID: 25022538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between neuropathology and brain volume in the Framingham Heart Study.
    Kaur B; Himali JJ; Seshadri S; Beiser AS; Au R; McKee AC; Auerbach S; Wolf PA; DeCarli CS
    Alzheimer Dis Assoc Disord; 2014; 28(3):219-25. PubMed ID: 24614264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
    Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
    Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.